Experimental Alzheimer’s drug shows some benefit
Innovating care in a tough-to-treat indicationIn its presentation on Wednesday, the company will unveil data showing whether or not solanezumab can halt Alzheimer’s disease progression in patients suffering from a mild form of the disease. Eric Siemers, medical director for...
Posted On Jul 22 2015